Research Associate with The Cameron Institute
Robert Freeman was one of the first leaders in health economics and outcomes research in the global pharmaceutical industry. He has directed and conducted comparative effectiveness research across a diverse portfolio of developmental and marketed products from preclinical to patent expiration in North American, Europe, Japan, and emerging country markets. He brings over 30 years’ experience in industry, academia and consulting in health economics and public policy. Prior to his return to academia, he was Executive Director, Public Policy, at AstraZeneca Pharmaceuticals where he was responsible for research and strategic policy on issues related to market access, international trade, drug counterfeiting and science policy.
He currently serves as Professor, Clinical Effectiveness and Outcomes Research, at Midway College School of Pharmacy in Kentucky.Most recently, he was Professor, Pharmaceutical Sciences, and Director of Graduate Studies at Texas A&M Health Science Center, Rangel College of Pharmacy. He has held faculty and administrative positions at The University of Iowa College of Pharmacy, The University of Alabama School of Medicine and The University of Mississippi School of Pharmacy. He earned his BS in Pharmacy, MS and Ph.D. in Health Administration from the University of Mississippi.
He is the author of over 75 refereed publications in prescription drug policy, pharmaceutical economics & finance and health technology assessments.